Structure-Guided Approach to Relieving Transcriptional Repression in Resistance to Thyroid Hormone α.
Published version
Peer-reviewed
Repository URI
Repository DOI
Change log
Authors
Abstract
Mutations in thyroid hormone receptor α (TRα), a ligand-inducible transcription factor, cause resistance to thyroid hormone α (RTHα). This disorder is characterized by tissue-specific hormone refractoriness and hypothyroidism due to the inhibition of target gene expression by mutant TRα-corepressor complexes. Using biophysical approaches, we show that RTHα-associated TRα mutants devoid of ligand-dependent transcription activation function unexpectedly retain the ability to bind thyroid hormone. Visualization of the ligand T3 within the crystal structure of a prototypic TRα mutant validates this notion. This finding prompted the synthesis of different thyroid hormone analogues, identifying a lead compound, ES08, which dissociates corepressor from mutant human TRα more efficaciously than T3. ES08 rescues developmental anomalies in a zebrafish model of RTHα and induces target gene expression in TRα mutation-containing cells from an RTHα patient more effectively than T3. Our observations provide proof of principle for developing synthetic ligands that can relieve transcriptional repression by the mutant TRα-corepressor complex for treatment of RTHα.
Description
Keywords
Journal Title
Conference Name
Journal ISSN
1098-5549
Volume Title
Publisher
Publisher DOI
Sponsorship
Medical Research Council (MC_UU_12012/5)
Wellcome Trust (210755/Z/18/Z)
European Commission (330183)
Medical Research Council (MC_PC_12012)